Continuous Glucose Monitor Market Remains In Abbott’s Sights
This article was originally published in The Gray Sheet
Executive Summary
Abbott says an FDA inspection of one third-party supplier is the only remaining barrier to PMA approval for its long-delayed Freestyle Navigator continuous glucose monitor
You may also be interested in...
Continuous Glucose Monitors: Best Data To Date, But Youths Pose Challenge
Continuous glucose monitor manufacturers expect research reported out of Rome last week will boost the still-nascent market for the products and help make the case for better reimbursement
Continuous Glucose Monitors: Best Data To Date, But Youths Pose Challenge
Continuous glucose monitor manufacturers expect research reported out of Rome last week will boost the still-nascent market for the products and help make the case for better reimbursement
Artificial Pancreas Support Grows, But 2011 Target Date May Be Optimistic
The Juvenile Diabetes Research Foundation hopes that development of an artificial pancreas will proceed fast enough to enable a commercial debut as soon as 2011. But some attendees at a recent public workshop on the effort caution that time-consuming hurdles remain, and that a market launch is not likely for several years thereafter